{"id":263200,"date":"2026-09-23T10:04:45","date_gmt":"2026-09-23T04:34:45","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=263200"},"modified":"2026-09-23T10:04:45","modified_gmt":"2026-09-23T04:34:45","slug":"anuh-pharma-best-stock-in-its-sector","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/anuh-pharma-best-stock-in-its-sector\/","title":{"rendered":"Is Anuh Pharma the Best Stock in Its Sector? A Look at the Numbers"},"content":{"rendered":"

Anuh Pharma CMP Rs 93 (23 Sep 2026). Market cap Rs 942 Cr. ROE 11.65%. P\/E 21.32x versus Industry P\/E 51.81x.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Anuh Pharma is one of the names investors compare when screening the Healthcare sector, built on a 11.65% return on equity and a P\/E of 21.32x against an Industry P\/E of 51.81x. Whether Anuh Pharma is the best stock in its sector depends on whether an investor is optimising for return ratios, valuation, or both. This article breaks down the metrics, including a comparison against named Healthcare sector peers, so you can judge that for yourself.<\/p>\n<\/p><\/div>\n

Is Anuh Pharma<\/a> the best stock in its sector? The stock trades on the NSE at Rs 93 as of 23 September 2026, within its 52-week range of Rs 67.00 to Rs 99.50. Anuh Pharma Ltd manufactures active pharmaceutical ingredients, particularly antibiotics, for domestic and export markets.<\/p>\n

Anuh Pharma sits in the Healthcare sector, and its 11.65% ROE and 21.32x P\/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector’s Industry P\/E benchmark.<\/p>\n

Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers<\/a><\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n